Left Long Valeant: A Technical Look

Valeant Pharmaceuticals Intl Inc VRX shares are trading higher by $1.15 at $27.05. The issue is getting a lift off the announcement that Andrew Left of Citron Research is long the issue.

Left was the one of the first to call out the issue as a short and is now trying it find from the long side.

Related Link: Valeant Spikes After Andrew Left Says He's Long The Stock, Out-Of-Money Puts

The issue reached its lowest level since November 2010 last week when it bottomed at $23.55. It rebounded to end the week at $25.90.

The news of Left's stake has for the moment pushed the issue beyond the pair of highs from Thursday ($26.67) and Friday ($26.60), jumping into the $27 handle, with $27.15 standing as the current high.

Market News and Data brought to you by Benzinga APIs
Comments
Loading...
Posted In: Short SellersTechnicalsIntraday UpdateMoversTrading IdeasAndrew LeftCitron Research
Benzinga simplifies the market for smarter investing

Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.

Join Now: Free!